The Project
Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancer cases and, for the majority of the patients, the diagnosis is performed in advanced stages...
The rationale lying behind CLARO is to convert medical images, radiomics and pathomics data, and the other useful information gathered from patients suffering from non-small cell lung cancer (NSCLC) into a signature, that is a clear and concise set of quantitative biomarkers. This signature, feeding machine learning-based decision support systems, will offer the possibility to select the right therapy for the right patient. This project will exploit the digital revolution that has been running over the life sciences to develop new approaches for personalized medicine in NSCLC.
Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancer cases and, for the majority of the patients, the diagnosis is performed in advanced stages...
The CLARO project aims at developing a RadioPathomics-based Decision Support Systems (RPDSSs) targeted at patients suffering from...
The CLARO work plan is broken down in 8 Work Packages (WP) addressing the project general objectives. The activities will be carried out ...
UCBM – Università Campus Bio-Medico di Roma – Project coordinator
The work will involve ...